查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2066116

監管服務外包市場：2026-2032年全球市場預測（按服務類型、外包模式、發展階段、治療領域、最終用戶和公司規模分類）

Regulatory Affairs Outsourcing Market by Service Type, Outsourcing Model, Development Phase, Therapeutic Area, End User, Company Size - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，監管事務外包市場將成長至 113.5 億美元，複合年成長率為 7.35%。

主要市場統計數據
基準年 2025 69億美元
預計年份：2026年 73.9億美元
預測年份 2032 113.5億美元
複合年成長率 (%) 7.35%

對於管理全球產品生命週期的製藥、生物技術、醫療設備和生命科學公司而言，監管事務外包正從戰術性支援模式轉變為策略營運能力。申辦公司越來越依賴外部監管事務夥伴來提交申請文件、監管資訊、標籤、化學、生產和品管(CMC) 文件、臨床試驗申請、上市後維護、藥物警戒協調以及與衛生監管機構的溝通。

這種需求是由檢驗的結構性壓力所驅動的。美國FDA、歐洲藥品管理局（EMA）、加拿大衛生署、日本PMDA、中國國家藥品監督管理局（NMPA）、印度CDSCO以及其他國家監管機構持續擴大電子申報管道、安全報告要求、產品特定指南和生命週期合規義務。隨著開發平臺日益涵蓋生物製藥、細胞和基因療法、組合產品、生物相似藥、體外診斷試劑和軟體驅動的醫療技術，監管外包服務能夠幫助企業提高申報品質、緩解內部能力限制，並確保符合不同地區的監管要求。

外包環境的變革性變化

全球協調與各國具體情況的複雜性正在共同重塑監管外包格局。儘管ICH指南、eCTD的採用、電子產品資訊舉措以及可靠性程序有助於規範申請流程的部分內容，但本地專業知識對於本地語言、標籤、藥品安全監測、資料居住要求和上市後要求仍然至關重要。

人工智慧（AI）的累積影響

人工智慧正透過改善文件分類、文獻監測、差距分析、申請資料整理、翻譯審核和監管情報監控，對整個監管外包流程產生累積效應。自然語言處理工具正在加速對指南更新、安全訊號、先例、臨床試驗揭露要求和特定國家/地區要求的審核，從而幫助監管團隊專注於科學策略和與衛生當局的合作。

主要市場的關鍵區域洞察

亞太地區是監管外包領域最具活力的地區之一，這主要得益於中國、印度、日本、韓國、澳洲和東協市場臨床試驗活動的不斷擴展、國內創新能力的提升以及核准流程的不斷完善。儘管該地區具備業務規模優勢和接觸多元化患者群體的能力，但申辦方必須有效應對國家藥品監督管理局 (NMPA)、中國藥品標準控制組織 (CDSCO)、中國藥品和醫療器械管理局 (PMDA)、韓國食品藥品安全部 (MFDS​​)、澳大利亞藥品管理局 (TGA) 以及東協各國監管機構的不同要求，尤其是在上市後市場和臨床數據、局部機構的影響

我們團隊對全球監管策略的主要見解

在東協，成員國之間的監管合作正在不斷加強，並透過區域協調努力變得日益重要；然而，實際操作仍需了解註冊時間表、語言要求、申請文件格式以及各國衛生部門的慣例。在海灣合作理事會（GCC），集中式和國家級監管管道正在發展，區域監管響應系統、藥物警戒基礎設施、產品分類、阿拉伯語標籤和上市後合規性對於產品進入海灣國家市場至關重要。

各國在監理事務外包方面的重點洞察。

在美國，高價值監管服務外包的需求最為旺盛，包括與FDA的溝通、IND、NDA、BLA、ANDA、510(k)、PMA、De Novo申請、標籤、REMS、臨床試驗申請以及上市後合規等。在加拿大，加拿大衛生部已建立成熟的法規環境，對雙語標籤、許可、臨床試驗申請和生命週期管理的需求日益成長。同時，在墨西哥和巴西，需要具備透過COFEPRIS和ANVISA流程進行在地化監管方面的專業知識，包括註冊文件、進口法規、GMP認證以及藥物安全監測的協調。

為行業領導者提供的實用建議

無論治療領域、產品類型或目標區域如何，產業領導者都應優先選擇經驗豐富的外包合作夥伴。優秀的供應商會將監管策略、出版物、標籤、藥物警戒協調、品質系統、監管資訊、對當地分支機構的支持以及與衛生監管機構的溝通整合到一個統一的管治模式下。

調查方法

本執行摘要是基於對製藥、生物技術、醫療設備、診斷和生命科學市場中公開的法規結構、衛生監管機構指南、行業標準和外包實踐的系統性審查。主要參考文獻包括美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA)、國際人用藥品註冊技術協調會 (ICH)、國際標準化組織 (ISO)、加拿大衛生署安全局、巴西藥品監督(ANVISA)、歐盟委員會以及相關國家監管機構發布的監管文件。

結論

外包監管事務正成為支撐全球生命科學產業競爭力的核心要素。隨著監管要求的數量、複雜性和數位化程度不斷提高，企業需要專業的合作夥伴來管理本地申請流程、生命週期義務、監管資訊監控、本地代理、安全協調以及與監管機構的溝通協調。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：監理服務外包市場：依服務類型分類

  • 顯示服務
    • 標籤設計
    • 標籤創建
  • 監理諮詢
    • 合規諮詢
    • 策略諮詢
    • 應用諮詢
  • 上市後監測
    • 安全報告
    • 不利事件監測
  • 監管資訊
    • 競爭資訊
    • 追蹤監管趨勢
  • 監理策略
    • 打入市場策略
    • 核准途徑策略
  • 應用程式管理
    • 文件創建
    • 準備申請文件
    • 應用程式計劃

第8章：監理服務外包市場：依外包模式分類

  • 完全外包
  • 一經請求
  • 部分外包

第9章：監理服務外包市場：依發展階段分類

  • 臨床前階段
  • 臨床階段
    • 第一階段
    • 第二階段
    • 第三階段
  • 應用階段
  • 經批准

第10章：監理服務外包市場：依治療領域分類

  • 腫瘤學
  • 神經病學
  • 免疫學和炎症
  • 感染疾病
  • 循環系統/代謝系統
  • 呼吸系統
  • 皮膚科

第11章：監理服務外包市場：依最終用戶分類

  • 生技公司
  • 受託研究機構
  • 醫療設備製造商
  • 製藥公司
  • 學名藥生產商
  • 消費者健康和非處方藥公司

第12章：監理服務外包市場：依公司規模分類

  • 大公司
  • 小型企業

第13章：監理服務外包市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：監理服務外包市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：監理服務外包市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Bentley Biomedical Consulting LLC
  • BlueReg Group
  • Catalyst Clinical Research, LLC
  • CCS Associates, Inc.
  • Celegence LLC
  • Charles River Laboratories International, Inc.
  • CliniExperts Private Limited
  • Criterium, Inc.
  • Facet Life Sciences
  • Freyr Solutions
  • Genpact Limited
  • Global Pharma Solutions LLC
  • ICON plc
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Lambda Therapeutic Research Ltd.
  • MakroCare
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • PharPoint Research, Inc.
  • Premier Research
  • ProPharma Group
  • Syneos Health Inc.
  • TFS HealthScience
  • Thermo Fisher Scientific Inc.
  • Veristat, LLC
  • WuXi AppTec Co., Ltd.
Product Code: MRR-A339DAEFA5EA

The Regulatory Affairs Outsourcing Market is projected to grow by USD 11.35 billion at a CAGR of 7.35% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.90 billion
Estimated Year [2026] USD 7.39 billion
Forecast Year [2032] USD 11.35 billion
CAGR (%) 7.35%

Regulatory affairs outsourcing has moved from a tactical support model to a strategic operating capability for pharmaceutical, biotechnology, medical device, and life sciences companies managing global product lifecycles. Sponsors increasingly rely on external regulatory affairs partners for dossier publishing, regulatory intelligence, labeling, chemistry, manufacturing, and controls documentation, clinical trial applications, post-approval maintenance, pharmacovigilance coordination, and health authority correspondence.

The demand is supported by verifiable structural pressures: the U.S. FDA, European Medicines Agency, Health Canada, Japan's PMDA, China's NMPA, India's CDSCO, and other national authorities continue to expand digital submission pathways, safety reporting expectations, product-specific guidance, and lifecycle compliance obligations. As development pipelines include more biologics, cell and gene therapies, combination products, biosimilars, in vitro diagnostics, and software-enabled medical technologies, outsourced regulatory affairs services help companies improve submission quality, reduce internal capacity constraints, and maintain compliance across fragmented regional requirements.

Transformative Shifts in the Outsourcing Landscape

The regulatory affairs outsourcing landscape is being reshaped by convergence between global harmonization and country-specific complexity. ICH guidelines, eCTD adoption, electronic product information initiatives, and reliance procedures are helping standardize parts of the submission process, while local language, labeling, pharmacovigilance, data residency, and post-market requirements continue to require specialized regional expertise.

Another major shift is the growing need for lifecycle regulatory management rather than one-time submission support. Companies are outsourcing renewals, variations, safety updates, labeling changes, regulatory intelligence monitoring, and global publishing to maintain continuous compliance. This change is particularly important as the EU Clinical Trials Regulation, EU Medical Device Regulation, EU In Vitro Diagnostic Regulation, FDA modernization initiatives, and real-world evidence frameworks increase the volume and frequency of regulatory interactions.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative gains across regulatory affairs outsourcing by improving document classification, literature surveillance, gap analysis, submission assembly, translation review, and regulatory intelligence monitoring. Natural language processing tools can accelerate the review of guidance updates, safety signals, labeling precedents, clinical trial disclosure obligations, and country-specific requirements, helping regulatory teams focus on scientific strategy and health authority engagement.

However, AI adoption in regulatory affairs remains governed by validation, auditability, data integrity, cybersecurity, privacy protection, and human oversight. The most effective outsourcing models combine AI-enabled workflow automation with experienced regulatory professionals who can interpret regulatory intent, manage agency interactions, and ensure that outputs align with FDA, EMA, ICH, ISO, Good Clinical Practice, and local authority expectations. This hybrid model improves speed while reducing the risk of noncompliant automated decisions.

Key Regional Insights Across Major Markets

Asia-Pacific is one of the most dynamic regions for regulatory affairs outsourcing due to expanding clinical trial activity, growing domestic innovation, and evolving approval pathways in China, India, Japan, South Korea, Australia, and ASEAN markets. The region offers operational scale and access to diverse patient populations, but sponsors must manage divergent requirements across NMPA, CDSCO, PMDA, MFDS, TGA, and national ASEAN authorities, particularly for local clinical data expectations, product registration, labeling, and post-approval variations.

North America remains a high-value regulatory affairs outsourcing region because of the FDA's global influence, Health Canada's mature review framework, strong life sciences investment, and demand for submission strategy, expedited pathways, labeling, regulatory operations, and post-approval maintenance. Europe is equally central, with EMA procedures, national competent authorities, the EU Clinical Trials Regulation, Medical Device Regulation, In Vitro Diagnostic Regulation, multilingual labeling, and pharmacovigilance obligations creating sustained demand for outsourced regulatory expertise. Latin America, the Middle East, and Africa are increasingly important for geographic expansion, where companies need local representation, product registration support, pricing and reimbursement documentation, safety reporting alignment, import authorization assistance, and market-specific lifecycle compliance.

Key Group Insights for Global Regulatory Strategy

ASEAN is gaining importance as regulatory cooperation improves across member states through regional harmonization initiatives, yet practical execution still requires local knowledge of registration timelines, language expectations, dossier formats, and country-specific health authority practices. The GCC is advancing centralized and national regulatory pathways, making regional regulatory representation, pharmacovigilance infrastructure, product classification, Arabic labeling, and post-market compliance important for market access across Gulf countries.

The European Union is a core hub for regulatory affairs outsourcing because centralized, decentralized, mutual recognition, and national procedures demand procedural precision, multilingual compliance, clinical trial transparency, and coordinated pharmacovigilance. BRICS markets are significant because China, India, Brazil, Russia, and South Africa combine large patient populations with evolving domestic regulatory systems and increasing expectations for local evidence, manufacturing quality, and post-approval surveillance. G7 markets continue to set global regulatory benchmarks for medicines, medical devices, biologics, diagnostics, and digital health technologies, while NATO-aligned countries often place heightened emphasis on supply chain resilience, quality systems, secure data governance, and continuity of critical life sciences operations.

Key Country Insights for Regulatory Affairs Outsourcing

The United States leads demand for high-value regulatory outsourcing through FDA interactions, INDs, NDAs, BLAs, ANDAs, 510(k)s, PMAs, De Novo requests, labeling, REMS, clinical trial submissions, and post-market commitments. Canada offers a mature Health Canada environment with strong needs in bilingual labeling, product licensing, clinical trial applications, and lifecycle maintenance, while Mexico and Brazil require localized regulatory expertise through COFEPRIS and ANVISA processes, including registration documentation, import controls, GMP evidence, and pharmacovigilance alignment.

In Europe, the United Kingdom, Germany, France, Italy, and Spain remain essential for market access, clinical research, decentralized procedures, national submissions, health technology documentation, and post-authorization management, while Russia requires careful navigation of national registration, localization requirements, and geopolitical constraints. China and India are major engines for regulatory outsourcing due to regulatory modernization, expanding domestic innovation, clinical development activity, and complex local compliance requirements. Japan, Australia, and South Korea offer sophisticated frameworks through PMDA, TGA, and MFDS, making them attractive but compliance-intensive markets for global sponsors that need precise dossier preparation, local representation, safety reporting, labeling, and lifecycle management.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize outsourcing partners with proven experience across therapeutic areas, product types, and target geographies. The strongest providers combine regulatory strategy, publishing, labeling, pharmacovigilance coordination, quality systems, regulatory intelligence, local affiliate support, and health authority communication under an integrated governance model.

Companies should also invest in standardized data models, validated AI tools, submission-ready document templates, structured content management, and regulatory intelligence workflows. Clear service-level agreements, audit trails, escalation procedures, data security controls, role-based accountability, and measurable quality indicators help ensure that outsourcing delivers speed without compromising compliance, scientific accuracy, inspection readiness, or agency credibility.

Research Methodology

This executive summary is based on a structured review of publicly available regulatory frameworks, health authority guidance, industry standards, and observed outsourcing practices across pharmaceutical, biotechnology, medical device, diagnostics, and life sciences markets. Key reference points include FDA, EMA, ICH, ISO, Health Canada, PMDA, NMPA, CDSCO, TGA, MFDS, ANVISA, European Commission, and national competent authority regulatory materials.

The analysis applies a qualitative market intelligence approach, integrating regulatory pathway assessment, regional comparison, service demand mapping, compliance requirement review, and technology impact evaluation. Insights are designed to support strategic decision-making while avoiding unsupported claims, unverified market sizing, market share statements, or speculative projections.

Conclusion

Regulatory affairs outsourcing is becoming a core enabler of global life sciences competitiveness. As regulatory requirements increase in volume, complexity, and digital intensity, sponsors need specialized partners that can manage submissions, lifecycle obligations, regulatory intelligence monitoring, local representation, safety coordination, and health authority engagement across regions.

The executive outlook is shaped by three forces: regulatory modernization, international expansion, and AI-enabled operational efficiency. Organizations that combine expert oversight with scalable technology, regional depth, secure data governance, and robust quality management will be best positioned to accelerate regulatory execution, protect compliance, improve inspection readiness, and strengthen long-term product value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Regulatory Affairs Outsourcing Market, by Service Type

  • 7.1. Labeling Services
    • 7.1.1. Label Artwork
    • 7.1.2. Label Creation
  • 7.2. Regulatory Consulting
    • 7.2.1. Compliance Consulting
    • 7.2.2. Strategy Consulting
    • 7.2.3. Submission Consulting
  • 7.3. Post Market Surveillance
    • 7.3.1. Safety Reporting
    • 7.3.2. Adverse Event Monitoring
  • 7.4. Regulatory Intelligence
    • 7.4.1. Competitive Intelligence
    • 7.4.2. Regulation Tracking
  • 7.5. Regulatory Strategy
    • 7.5.1. Market Entry Strategy
    • 7.5.2. Pathway Strategy
  • 7.6. Submission Management
    • 7.6.1. Document Preparation
    • 7.6.2. Dossier Compilation
    • 7.6.3. Submission Planning

8. Regulatory Affairs Outsourcing Market, by Outsourcing Model

  • 8.1. Full Outsourcing
  • 8.2. On Demand
  • 8.3. Partial Outsourcing

9. Regulatory Affairs Outsourcing Market, by Development Phase

  • 9.1. Pre-Clinical Phase
  • 9.2. Clinical Phase
    • 9.2.1. Phase I
    • 9.2.2. Phase II
    • 9.2.3. Phase III
  • 9.3. Submission Phase
  • 9.4. Post-Approval

10. Regulatory Affairs Outsourcing Market, by Therapeutic Area

  • 10.1. Oncology
  • 10.2. Neurology
  • 10.3. Immunology & Inflammation
  • 10.4. Infectious Diseases
  • 10.5. Cardiovascular & Metabolic
  • 10.6. Respiratory
  • 10.7. Dermatology

11. Regulatory Affairs Outsourcing Market, by End User

  • 11.1. Biotechnology Companies
  • 11.2. Contract Research Organizations
  • 11.3. Medical Device Manufacturers
  • 11.4. Pharmaceutical Companies
  • 11.5. Generic Drug Manufacturers
  • 11.6. Consumer Health & OTC Product Companies

12. Regulatory Affairs Outsourcing Market, by Company Size

  • 12.1. Large Enterprises
  • 12.2. SMEs

13. Regulatory Affairs Outsourcing Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Regulatory Affairs Outsourcing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Regulatory Affairs Outsourcing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Bentley Biomedical Consulting LLC
  • 17.2. BlueReg Group
  • 17.3. Catalyst Clinical Research, LLC
  • 17.4. CCS Associates, Inc.
  • 17.5. Celegence LLC
  • 17.6. Charles River Laboratories International, Inc.
  • 17.7. CliniExperts Private Limited
  • 17.8. Criterium, Inc.
  • 17.9. Facet Life Sciences
  • 17.10. Freyr Solutions
  • 17.11. Genpact Limited
  • 17.12. Global Pharma Solutions LLC
  • 17.13. ICON plc
  • 17.14. IQVIA Holdings Inc.
  • 17.15. Laboratory Corporation of America Holdings
  • 17.16. Lambda Therapeutic Research Ltd.
  • 17.17. MakroCare
  • 17.18. Medpace Holdings, Inc.
  • 17.19. Parexel International Corporation
  • 17.20. PharPoint Research, Inc.
  • 17.21. Premier Research
  • 17.22. ProPharma Group
  • 17.23. Syneos Health Inc.
  • 17.24. TFS HealthScience
  • 17.25. Thermo Fisher Scientific Inc.
  • 17.26. Veristat, LLC
  • 17.27. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LABELING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LABELING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LABELING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LABEL ARTWORK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LABEL ARTWORK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LABEL ARTWORK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LABEL CREATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LABEL CREATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LABEL CREATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REGULATORY CONSULTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REGULATORY CONSULTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REGULATORY CONSULTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPLIANCE CONSULTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COMPLIANCE CONSULTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPLIANCE CONSULTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STRATEGY CONSULTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STRATEGY CONSULTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STRATEGY CONSULTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SUBMISSION CONSULTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SUBMISSION CONSULTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SUBMISSION CONSULTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POST MARKET SURVEILLANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POST MARKET SURVEILLANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POST MARKET SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SAFETY REPORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SAFETY REPORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SAFETY REPORTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ADVERSE EVENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ADVERSE EVENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ADVERSE EVENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL REGULATORY INTELLIGENCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL REGULATORY INTELLIGENCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL REGULATORY INTELLIGENCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COMPETITIVE INTELLIGENCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPETITIVE INTELLIGENCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COMPETITIVE INTELLIGENCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL REGULATION TRACKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL REGULATION TRACKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL REGULATION TRACKING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REGULATORY STRATEGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REGULATORY STRATEGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL REGULATORY STRATEGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MARKET ENTRY STRATEGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MARKET ENTRY STRATEGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MARKET ENTRY STRATEGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PATHWAY STRATEGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PATHWAY STRATEGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PATHWAY STRATEGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SUBMISSION MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SUBMISSION MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SUBMISSION MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DOCUMENT PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DOCUMENT PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DOCUMENT PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DOSSIER COMPILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DOSSIER COMPILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DOSSIER COMPILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SUBMISSION PLANNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SUBMISSION PLANNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SUBMISSION PLANNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FULL OUTSOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FULL OUTSOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FULL OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ON DEMAND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ON DEMAND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ON DEMAND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PARTIAL OUTSOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PARTIAL OUTSOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PARTIAL OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PRE-CLINICAL PHASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PRE-CLINICAL PHASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PRE-CLINICAL PHASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CLINICAL PHASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CLINICAL PHASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CLINICAL PHASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHASE I MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHASE I MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHASE I MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHASE II MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHASE II MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHASE II MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHASE III MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHASE III MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHASE III MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SUBMISSION PHASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SUBMISSION PHASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SUBMISSION PHASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL POST-APPROVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL POST-APPROVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL POST-APPROVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CARDIOVASCULAR & METABOLIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIOVASCULAR & METABOLIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CARDIOVASCULAR & METABOLIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL RESPIRATORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL RESPIRATORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL RESPIRATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL DERMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL GENERIC DRUG MANUFACTURERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL GENERIC DRUG MANUFACTURERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL GENERIC DRUG MANUFACTURERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CONSUMER HEALTH & OTC PRODUCT COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CONSUMER HEALTH & OTC PRODUCT COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CONSUMER HEALTH & OTC PRODUCT COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL SMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL SMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 247. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 248. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 249. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 250. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 251. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 252. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 253. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 254. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 255. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. GCC REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 288. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 289. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 290. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 291. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 292. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 293. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 294. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 295. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 296. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 297. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. G7 REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 302. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 303. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 304. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 305. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 306. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 307. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 308. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 309. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 310. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 311. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. NATO REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. GLOBAL REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SUBMISSION MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2032 (USD MILLION)
  • TABLE 328. CANADA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. CANADA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. CANADA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY LABELING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 331. CANADA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, 2018-2032 (USD MILLION)
  • TABLE 332. CANADA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, BY POST MARKET SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 333. CANADA REGULATORY AFFAIRS OUTSOURCING MARKET SIZE, B